SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-012564
Filing Date
2021-09-16
Accepted
2021-09-16 16:11:15
Documents
12
Period of Report
2021-09-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tmbr-20210914x8k.htm   iXBRL 8-K 33308
  Complete submission text file 0001558370-21-012564.txt   154769

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmbr-20210914.xsd EX-101.SCH 3046
3 EX-101.LAB tmbr-20210914_lab.xml EX-101.LAB 17420
4 EX-101.PRE tmbr-20210914_pre.xml EX-101.PRE 10218
5 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20210914x8k_htm.xml XML 4866
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 211258070
SIC: 2834 Pharmaceutical Preparations